1. Home
  2. VNDA vs AUDC Comparison

VNDA vs AUDC Comparison

Compare VNDA & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • AUDC
  • Stock Information
  • Founded
  • VNDA N/A
  • AUDC N/A
  • Country
  • VNDA United States
  • AUDC Israel
  • Employees
  • VNDA N/A
  • AUDC N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • VNDA Health Care
  • AUDC Utilities
  • Exchange
  • VNDA Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • VNDA 362.6M
  • AUDC 304.5M
  • IPO Year
  • VNDA 2006
  • AUDC 1999
  • Fundamental
  • Price
  • VNDA $6.11
  • AUDC $10.79
  • Analyst Decision
  • VNDA Buy
  • AUDC Buy
  • Analyst Count
  • VNDA 1
  • AUDC 2
  • Target Price
  • VNDA $11.00
  • AUDC $12.00
  • AVG Volume (30 Days)
  • VNDA 867.4K
  • AUDC 97.7K
  • Earning Date
  • VNDA 07-29-2024
  • AUDC 07-30-2024
  • Dividend Yield
  • VNDA N/A
  • AUDC 3.21%
  • EPS Growth
  • VNDA N/A
  • AUDC N/A
  • EPS
  • VNDA N/A
  • AUDC 0.36
  • Revenue
  • VNDA $177,604,000.00
  • AUDC $245,246,000.00
  • Revenue This Year
  • VNDA $2.98
  • AUDC $2.14
  • Revenue Next Year
  • VNDA $19.49
  • AUDC $3.74
  • P/E Ratio
  • VNDA N/A
  • AUDC $29.67
  • Revenue Growth
  • VNDA N/A
  • AUDC N/A
  • 52 Week Low
  • VNDA $3.30
  • AUDC $7.14
  • 52 Week High
  • VNDA $6.75
  • AUDC $14.45
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 58.51
  • AUDC 53.84
  • Support Level
  • VNDA $5.89
  • AUDC $10.66
  • Resistance Level
  • VNDA $6.33
  • AUDC $11.38
  • Average True Range (ATR)
  • VNDA 0.25
  • AUDC 0.24
  • MACD
  • VNDA 0.05
  • AUDC 0.00
  • Stochastic Oscillator
  • VNDA 81.67
  • AUDC 55.30

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: